Search research articles
Contact Us
Filters
Showing results (91-100 of 143) with videos related to
Page
of 15
Sort By:
Clinical Endocrinology
|
November 3, 1998
Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma
J M Fernández-Real, W R Engel, R Simó, et al.
Nature Communications
|
April 3, 2025
Author Correction: Marine biogenic humic substances control iron biogeochemistry across the Southern Ocean
C S Hassler, R Simó, S E Fawcett, et al.
American Journal of Ophthalmology
|
March 8, 2000
Serum laminin as a marker of diabetic retinopathy development: a 4-year follow-up study
L Masmiquel, R M Segura, C Mateo, et al.
The British Journal of Ophthalmology
|
June 30, 2000
Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy
A Cantón, R Burgos, C Hernández, et al.
Histopathology
|
January 16, 2007
Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma
C Zafon, G Obiols, J Castellví, et al.
Diabetologia
|
September 23, 1997
Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy
R Burgos, R Simó, L Audí, et al.
Clinical Cardiology
|
May 1, 1986
Probable early acute hepatitis with parenteral amiodarone
J Lupon-Rosés, R Simó-Canonge, L Lu-Cortez, et al.
Nephron
|
January 1, 1996
Which factors account for increased serum laminin levels in patients with chronic renal diseases?
A Segarra, L L Masmiquel, R Simó, et al.
Journal of Clinical Pathology
|
February 1, 1997
Leu-M1 immunoreactivity and phaeochromocytoma
L Masmiquel, M Castro-Forns, I de Torres, et al.
Medicina Clinica
|
May 7, 1988
[Treatment of Graves-Basedow disease with individualized doses of I-131]
R Simó, J Mesa, L García, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 143) with videos related to
Sort By:
Page
of 15
Clinical Endocrinology
|
November 3, 1998
Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma
J M Fernández-Real, W R Engel, R Simó, et al.
Nature Communications
|
April 3, 2025
Author Correction: Marine biogenic humic substances control iron biogeochemistry across the Southern Ocean
C S Hassler, R Simó, S E Fawcett, et al.
American Journal of Ophthalmology
|
March 8, 2000
Serum laminin as a marker of diabetic retinopathy development: a 4-year follow-up study
L Masmiquel, R M Segura, C Mateo, et al.
The British Journal of Ophthalmology
|
June 30, 2000
Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy
A Cantón, R Burgos, C Hernández, et al.
Histopathology
|
January 16, 2007
Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma
C Zafon, G Obiols, J Castellví, et al.
Diabetologia
|
September 23, 1997
Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy
R Burgos, R Simó, L Audí, et al.
Clinical Cardiology
|
May 1, 1986
Probable early acute hepatitis with parenteral amiodarone
J Lupon-Rosés, R Simó-Canonge, L Lu-Cortez, et al.
Nephron
|
January 1, 1996
Which factors account for increased serum laminin levels in patients with chronic renal diseases?
A Segarra, L L Masmiquel, R Simó, et al.
Journal of Clinical Pathology
|
February 1, 1997
Leu-M1 immunoreactivity and phaeochromocytoma
L Masmiquel, M Castro-Forns, I de Torres, et al.
Medicina Clinica
|
May 7, 1988
[Treatment of Graves-Basedow disease with individualized doses of I-131]
R Simó, J Mesa, L García, et al.
Page
of 15